無料プレビュー

Becton, Dickinson and Company (BDXA) · New York Stock Exchange

プロフィール

Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug

主要指標

株価: $59.24 (-2.24%)
時価総額: 559億ドル
PER（今期予想）: —
PBR: 2.5
配当利回り: —
52週レンジ: $49.07 – $64.12
業種: Healthcare / Medical - Instruments & Supplies
上場: New York Stock Exchange
構成銘柄: —

比較会社: ISRG Intuitive Surgical, Inc.、VRNA Verona Pharma plc、COR Cencora, Inc.、BDX Becton, Dickinson and Company、SGEN Seagen Inc.、RMD ResMed Inc.、MDLN Medline Inc.、WST West Pharmaceutical Services, Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

更新: 2026-10-09